Plain-English translation of NCT07402109 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing stereotactic body radiation therapy (SBRT) — a type of focused radiation treatment — for people with kidney cancer that has not spread. The study uses special imaging scans to precisely target the tumor while sparing healthy kidney tissue. The first group of patients will receive extra imaging scans to help doctors understand how the body moves during treatment, and this information will help improve the treatment plan for the second group.
Radiation therapy for kidney cancer currently requires markers placed on the skin to track the tumor during treatment. This trial is testing whether special imaging and breath-holding techniques can achieve the same precision without these markers, potentially making treatment simpler and reducing radiation exposure to surrounding healthy tissues.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive stereotactic radiation therapy — a focused treatment delivered over several sessions. The first 15 participants will receive extra imaging scans after each treatment session to help researchers understand how the body moves during radiation. The remaining 25 participants will receive treatment using motion-tracking techniques developed from that imaging data. You'll be asked to hold your breath at specific times during treatment to keep the tumor in a stable position.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Netherlands
Sponsor
Erasmus Medical Center
Enrollment target
~40 participants
Started
April 2026
Primary completion
January 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.